Will a vaccine for HIV be approved by the FDA and be available for public use by 2027?

The market shows a low probability for FDA approval of an HIV vaccine by 2027.

Current market sentiment indicates an 84.6% likelihood that an HIV vaccine will not be approved by the FDA by 2027. The Pulse AI suggests a slightly higher probability of 20.9% for approval, but overall confidence remains moderate at 55/100, reflecting uncertainty in the data.

• 1 Current market probability for approval is low at 15.40%.
• 2 Pulse AI suggests a slightly higher probability at 20.9%.
• 3 Market confidence is moderate, indicating uncertainty.
• 4 The edge of 5.5 suggests insufficient data for a confident assessment.
• 5 Time to expiry is substantial at 6966 hours, allowing for potential developments.